Inbiogen Secures Total Funding of 60 Billion KRW... "Decides on CB Issuance and Rights Offering"
[Asia Economy Reporter Hyunseok Yoo] Invbiogen announced on the 24th that it has decided to conduct a third-party allotment paid-in capital increase worth 30 billion KRW targeting its largest shareholder, Bucket Studio Co., Ltd., to acquire securities of other corporations. A total of 8,086,254 preferred shares will be newly issued. The issue price per new share is 3,710 KRW.
Hot Picks Today
!["Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/93/2025061015355092669_1749537351.jpg)
"Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- "Can't Even Turn On a Fan? How Will They Endure the Heat?"... Massive Blackout Hits the Philippines Amid Scorching Heat
- "Drink Three Cups of Coffee and Stay Up All Night Before the Test"... Manual of Insurance Planner Who Collected 1 Billion Won in Payouts
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
At the same time, it will also issue the 8th series convertible bonds (CB) worth 30 billion KRW to BSM No.1 Association. The bond maturity date is February 7, 2025. The coupon rate and maturity interest rate are 1.0% and 2.0%, respectively, and the conversion price is 4,148 KRW. The conversion request period is from February 7, 2023, to January 7, 2025.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
